IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity

Journal of Infectious Diseases

Volumn 206, Issue 2, 2012, Pages 197-201

  Van De Veerdonk, Frank L ^a   Wever, Peter C ^b   Hermans, Mirjam H A ^b   Fijnheer, Rob ^b   Joosten, Leo A B ^a   Van Der Meer, Jos W M ^a   Netea, Mihai G ^a   Schneeberger, Peter M ^b  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JEROEN BOSCH HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FERRITIN; INTERLEUKIN 8;

ADULT; ARTICLE; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; EPSTEIN BARR VIRUS INFECTION; FEMALE; HUMAN; INFECTIOUS MONONUCLEOSIS; INFLAMMATION; LYMPHOPROLIFERATIVE DISEASE; MALE; MYCOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; VIRUS INFECTION;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; BIOLOGICAL MARKERS; CAPSID; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; FERRITINS; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-18; MALE; REAL-TIME POLYMERASE CHAIN REACTION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84862838077     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis335     Document Type: Article

References (15)

1. Gulley ML, Tang W. Laboratory assays for Epstein-Barr virus-related disease. J Mol Diagn 2008; 10:279-92.
2. Dinarello CA. Interleukin-18, a proinflammatory cytokine. Eur Cytokine Netw 2000; 11:483-6.
3. Watanabe D, Uehira T, Yonemoto H, et al. Sustained high levels of serum interferon-gamma during HIV-1 infection: a specific trend different from other cytokines. Viral Immunol 2010; 23:619-25.
4. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2001; 30:229-33.
5. Setsuda J, Teruya-Feldstein J, Harris NL, et al. Interleukin-18, interferon-gamma, IP-10, and Mig expression in Epstein-Barr virus-induced infectious mononucleosis and posttransplant lymphoproliferative disease. Am J Pathol 1999; 155:257-65.
6. Yao L, Setsuda J, Sgadari C, Cherney B, Tosato G. Interleukin-18 expression induced by Epstein-Barr virus-infected cells. J Leukoc Biol 2001; 69:779-84.
7. Balfour HH Jr, Holman CJ, Hokanson KM, et al. A prospective clinical study of Epstein-Barr virus and host interactions during acute infectious mononucleosis. J Infect Dis 2005; 192:1505-12.
8. Niesters HG, van Esser J, Fries E, Wolthers KC, Cornelissen J, Osterhaus AD. Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000; 38:712-5.
9. van Doornum GJ, Guldemeester J, Osterhaus AD, Niesters HG. Diagnosing herpesvirus infections by real-time amplification and rapid culture. J Clin Microbiol 2003; 41:576-80.
10. Stuyt RJ, Netea MG, Verschueren I, Dinarello CA, Kullberg BJ, van der Meer JW. Interleukin-18 does not modulate the acute-phase response. J Endotoxin Res 2005; 11:85-8.
11. Liu CZ, Wang W, Zhou YD, He HX. [Clinical significance of the changes of serum interleukin-18 and tumor necrosis factor-alpha levels in children with infectious mononucleosis]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2010; 26:480-1.
12. Kim SH, Eisenstein M, Reznikov L, et al. Structural requirements of six naturally occurring isoforms of the IL-18 binding protein to inhibit IL-18. P Natl Acad Sci USA 2000; 97:1190-5.
13. Novick D, Kim S-H, Fantuzzi G, Reznikov LL, Dinarello CA, Rubinstein M. Interleukin-18 binding protein: a novel modulator of the Th1 cytokine response. Immunity 1999; 10:127-36.
14. Swanink CM, Vercoulen JH, Bleijenberg G, Fennis JF, Galama JM, van der Meer JW. Chronic fatigue syndrome: a clinical and laboratory study with a well matched control group. J InternMed 1995; 237:499-506.
15. Mazodier K, Marin V, Novick D, et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. Blood 2005; 106:3483-9.